Erik Atkisson - Aug 9, 2023 Form 4 Insider Report for Rain Oncology Inc. (RAIN)

Role
General Counsel and CCO
Signature
/s/ Avanish Vellanki, Attorney-in-fact for Erik Atkisson
Stock symbol
RAIN
Transactions as of
Aug 9, 2023
Transactions value $
$0
Form type
4
Date filed
8/11/2023, 09:04 PM
Previous filing
Mar 3, 2023
Next filing
Jan 26, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAIN Stock Option (Right to Buy) Award $0 +60.3K $0.00 60.3K Aug 9, 2023 Common Stock 60.3K $1.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 60,251 shares of the Issuer's common stock, one half of which will vest on May 9, 2024, with the remaining one half vesting in full on February 9, 2025, subject to the Reporting Person's continued service to the Issuer.